Aligning Investments in Therapeutic Development with Therapeutic Need Closing the Gap (2025) / Chapter Skim
Currently Skimming:


Pages 219-222

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 219...
... For more than 2 decades, Dr. Nass has worked on a broad range of health and science policy topics which includes the quality, safety, and equity of health care and clinical trials; developing technologies for precision medicine; and strategies to support clinician well-being.
From page 220...
... 220 ALIGNING INVESTMENTS IN THERAPEUTIC DEVELOPMENT Science and Technology Policy Graduate Fellow. She has also been an associate at AmericaSpeaks, a nonprofit organization that engaged citizens in decision making on important public policy issues.
From page 221...
... Dr. Scott Howell was determined to have a conflict of interest in relation to service on the Committee on Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs based on his current role with Blue Line Advisors, LLC, through which he provides ad hoc consulting to companies such as Jazz Pharmaceuticals.
From page 222...
... Dr. Edith Perez was determined to have a conflict of interest in relation to service on the Committee on Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs based on her role as chief medical officer at Bolt Biotherapeutics, which develops therapeutics to treat numerous cancers.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.